Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

ESG Investment Europe

On Tuesday, 03 November 2020, Damiano de Felice, Director of Strategy at the Access to Medicine Foundation, will join Reuters' virtual ESG Investment Europe conference to discuss the challenges and solutions of using and creating reliable ESG data.

Date

03 November 2020

The ESG Investment Europe 2020 conference is a summit where European investment professionals can learn from their peers about ESG integration strategies. The two-day event will feature 30+ leading executive speakers, eight-panel sessions, six presentations and six exclusive 1-1 interview led by Reuters News. 

Damiano de Felice will participate in the panel "Overcome the Incomparability of ESG Data Sets: Useable Data to Drive Decision-Making" as a part of the day's overarching Regulation and ESG Drivers theme. In his remarks, Damiano will discuss:

  • How the Access to Medicine Foundation creates ESG data 

  • The challenges in creating reputable and reliable ESG data for investors

  • How investors in pharmaceutical companies can make better use of ESG data

The panel will be moderated by Pedro Fernandez, Head of Sustainability, responsAbility Investments AG. Other speakers on the panel include:

  • Lupin Rahman, Head of EM Sovereign Credit, PIMCO

  • Justin Kew, ESG Analyst, Carmignac

  • Dimitri Kyriakou, Senior Content and Technology Specialist, Europe, FACTSET

The full agenda for ESG Investment Europe 2020 can be found here.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved